The rapid evolution of AI in healthcare brings transformative tools and personalized treatment options, but it carries significant risks. Both Federal and State officials are investigating and developing regulations to ensure the decision making models that healthcare providers, pharmaceutical companies, and biotech firms employ are not violating patient rights or inadvertently contributing to adverse outcomes.
In this episode, ModelOp’s Dave Trier will take you through the big regulatory themes shaping AI implementation in healthcare, pharmaceuticals, and biotech. You’ll gain a strategic understanding of the regulatory risks and best practices for implementing governance frameworks. With several key dates and deadlines approaching, this is your chance to align your business with upcoming regulatory changes and ensure your AI Governance capabilities are robust and adaptable.
Download the slide deck.
For a deeper dive on the topic, check out latest whitepaper: 2024 Outlook for AI Regulations
